Table 2.
Initial presenting symptoms and comorbidities of COVID-19 patients
| Variables | Frequency (%) |
|---|---|
| Initial presenting symptom (n = 222) | |
| Asymptomatic | 41 (18.5) |
| Symptomatic | 181 (81.5) |
| Presenting symptoms (n = 181, multiple response) | |
| Fever | 98 (54.1) |
| Loss of smell | 91 (50.3) |
| Cough | 56 (30.9) |
| Muscle ache | 53 (29.3) |
| Headache | 52 (28.7) |
| Malaise | 41 (22.7) |
| Dyspnea | 40 (22.1) |
| Sneezing | 37 (20.4) |
| Loss of taste | 29 (16.0) |
| Sore throat | 27 (14.9) |
| Chill | 22 (12.2) |
| Diarrhea | 22 (12.2) |
| Nausea and vomiting | 14 (7.7) |
| Comorbidity (n = 222) | |
| No | 138 (62.2) |
| Yes | 84 (37.8) |
| Comorbid diseases (n = 84, multiple response) | |
| Hypertension | 49 (58.3) |
| Diabetes mellitus | 25 (29.8) |
| Heart disease | 22 (26.2) |
| Hematological disease | 10 (11.9) |
| Stroke | 4 (4.8) |
| Chronic lungs disease | 4 (4.8) |
| Hepatitis B virus infection | 3 (3.6) |
| Hepatitis C virus infection | 2 (2.4) |
| Cirrhosis of liver | 1 (1.2) |
| Cancer | 1 (1.2) |